Cite

HARVARD Citation

    Chin, C. et al. (2020). Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma. Leukemia & lymphoma. 61 (12), pp. 2985-2989. [Online]. 
  
Back to record